A detailed history of Janus Henderson Group PLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,813,163 shares of DYN stock, worth $204 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
6,813,163
Previous 4,623,824 47.35%
Holding current value
$204 Million
Previous $163 Million 49.98%
% of portfolio
0.13%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$31.94 - $47.04 $69.9 Million - $103 Million
2,189,339 Added 47.35%
6,813,163 $245 Million
Q2 2024

Aug 14, 2024

BUY
$23.65 - $35.63 $46.1 Million - $69.4 Million
1,948,584 Added 72.84%
4,623,824 $163 Million
Q1 2024

May 15, 2024

BUY
$13.06 - $29.18 $34.8 Million - $77.7 Million
2,663,910 Added 23512.0%
2,675,240 $76 Million
Q4 2023

Feb 14, 2024

SELL
$6.62 - $13.64 $225 - $463
-34 Reduced 0.3%
11,330 $150,000
Q3 2023

Nov 14, 2023

BUY
$8.6 - $12.18 $120 - $170
14 Added 0.12%
11,364 $101,000
Q2 2023

Aug 14, 2023

BUY
$8.53 - $14.28 $93 - $157
11 Added 0.1%
11,350 $127,000
Q1 2023

May 15, 2023

BUY
$10.88 - $15.0 $123,368 - $170,085
11,339 New
11,339 $130,000
Q3 2022

Nov 14, 2022

SELL
$7.2 - $15.17 $2.12 Million - $4.47 Million
-294,348 Reduced 27.76%
765,953 $9.73 Million
Q2 2022

Aug 15, 2022

SELL
$4.36 - $10.5 $533,685 - $1.29 Million
-122,405 Reduced 10.35%
1,060,301 $7.29 Million
Q1 2022

May 16, 2022

BUY
$6.52 - $12.27 $3.91 Million - $7.37 Million
600,408 Added 103.11%
1,182,706 $11.4 Million
Q4 2021

Feb 14, 2022

BUY
$11.89 - $16.07 $283,160 - $382,707
23,815 Added 4.26%
582,298 $6.92 Million
Q3 2021

Nov 16, 2021

SELL
$15.6 - $21.46 $135,454 - $186,337
-8,683 Reduced 1.53%
558,483 $9.07 Million
Q2 2021

Aug 16, 2021

SELL
$15.94 - $22.33 $4.73 Million - $6.63 Million
-296,908 Reduced 34.36%
567,166 $11.9 Million
Q1 2021

May 17, 2021

BUY
$14.0 - $29.3 $3.28 Million - $6.86 Million
234,222 Added 37.19%
864,074 $13.4 Million
Q4 2020

Feb 16, 2021

SELL
$16.81 - $23.94 $5.99 Million - $8.53 Million
-356,111 Reduced 36.12%
629,852 $13.2 Million
Q3 2020

Nov 16, 2020

BUY
$20.0 - $23.9 $19.7 Million - $23.6 Million
985,963 New
985,963 $19.9 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.55B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.